Jpmorgan Chase & CO Insmed Inc Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Insmed Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 23,047,676 shares of INSM stock, worth $4.42 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares

23,047,676

Previous 6,354,022 262.73%

Holding current value

$4.42 Billion

Previous $485 Million 584.71%

% of portfolio

0.22%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$96.14 - $147.2 $1.6 Billion - $2.46 Billion	16,693,654 Added 262.73%	23,047,676 $3.32 Billion
Q1 2025 May 12, 2025	BUY	$65.25 - $83.83 $200 Million - $257 Million	3,067,774 Added 93.35%	6,354,022 $485 Million
Q4 2024 Feb 12, 2025	SELL	$66.29 - $76.63 $1.33 Million - $1.54 Million	-20,098 Reduced 0.61%	3,286,248 $227 Million
Q3 2024 Dec 26, 2024	BUY	$62.0 - $79.01 $23.6 Million - $30 Million	380,161 Added 12.99%	3,306,346 $241 Million
Q3 2024 Nov 08, 2024	BUY	$62.0 - $79.01 $23.6 Million - $30 Million	380,161 Added 12.99%	3,306,346 $241 Million
Q2 2024 Dec 26, 2024	SELL	$22.0 - $69.71 $8.36 Million - $26.5 Million	-380,161 Reduced 11.5%	2,926,185 $196 Million
Q2 2024 Aug 12, 2024	BUY	$22.0 - $69.71 $58 Million - $184 Million	2,636,654 Added 910.66%	2,926,185 $196 Million
Q1 2024 Dec 26, 2024	SELL	$25.72 - $29.94 $77.6 Million - $90.3 Million	-3,016,815 Reduced 91.24%	289,531 $7.85 Million
Q1 2024 May 10, 2024	SELL	$25.72 - $29.94 $2.39 Million - $2.78 Million	-92,963 Reduced 24.3%	289,531 $7.85 Million
Q4 2023 Dec 26, 2024	SELL	$23.42 - $31.74 $68.5 Million - $92.8 Million	-2,923,852 Reduced 88.43%	382,494 $11.9 Million
Q4 2023 Feb 12, 2024	SELL	$23.42 - $31.74 $596,530 - $808,449	-25,471 Reduced 6.24%	382,494 $11.9 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $931,573 - $1.26 Million	46,907 Added 12.99%	407,965 $10.3 Million
Q2 2023 Aug 11, 2023	BUY	$16.44 - $21.1 $1.12 Million - $1.44 Million	68,169 Added 23.27%	361,058 $7.62 Million
Q1 2023 May 18, 2023	BUY	$16.26 - $21.73 $2.76 Million - $3.69 Million	169,906 Added 138.15%	292,889 $4.99 Million
Q1 2023 May 11, 2023	SELL	$16.26 - $21.73 $4.34 Million - $5.8 Million	-267,016 Reduced 68.47%	122,983 $2.1 Million
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $2.23 Million - $3.04 Million	131,475 Added 50.86%	389,999 $7.79 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $2.25 Million - $3.04 Million	-107,720 Reduced 29.41%	258,524 $5.57 Million
Q2 2022 Aug 11, 2022	BUY	$17.07 - $25.71 $4.35 Million - $6.54 Million	254,542 Added 227.88%	366,244 $7.22 Million
Q1 2022 May 11, 2022	BUY	$20.42 - $28.13 $322,105 - $443,722	15,774 Added 16.44%	111,702 $2.63 Million
Q4 2021 Feb 10, 2022	SELL	$25.89 - $33.45 $2.63 Million - $3.4 Million	-101,761 Reduced 51.48%	95,928 $2.61 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $4.44 Million - $5.83 Million	197,689 New	197,689 $5.44 Million

Others Institutions Holding INSM

# of Institutions

626

Shares Held

220M

Call Options Held

2.99M

Put Options Held

3.32M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $26B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Insmed Inc Transaction History